Asset Details
Do you wish to reserve the book?
Clinical Significance of the Glasgow Prognostic Score for Survival after Colorectal Cancer Surgery
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Clinical Significance of the Glasgow Prognostic Score for Survival after Colorectal Cancer Surgery
Do you wish to request the book?
Clinical Significance of the Glasgow Prognostic Score for Survival after Colorectal Cancer Surgery
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Clinical Significance of the Glasgow Prognostic Score for Survival after Colorectal Cancer Surgery
2016
Overview
Glasgow prognostic score (GPS) has been found to be a useful tool in various cancer types. Our aim was to evaluate the significance of GPS in patients operated on for colorectal cancer (CRC). Patients with CRC who underwent radical resections between April 2010 and January 2015 were retrospectively evaluated. GPS was estimated based on the preoperative measurement of C-reactive protein and serum albumin levels. Data including demographics, laboratory and pathological parameters, surgical outcomes, and late-term follow-up results were analyzed. The study group of 115 patients consisted of 51 (44 %) women and 64 (56 %) men with a median age of 66 (range 32–91) years. The mean follow-up period was 20 (range 7–41) months. Tumor size and wound infection rates were significantly increased in patients with higher GPS (
p
= 0.019 and
p
= 0.003, respectively). According to multivariate analyses, CEA and GPS were found to be independent risk factors significantly effecting mortality (
p
= 0.001 and
p
= 0.009, respectively). At the end of the late-term follow-up period, it was detected that cancer-specific survival significantly decreased as the GPS increased (
p
= 0.016). The GPS is a significant prognostic factor in CRC and should be included in the routine preoperative assessment of all surgically treated CRC patients.
Publisher
Springer US,Springer Nature B.V
Subject
